Evaluation of IL-35, as a Possible Biomarker for Follow-Up after Therapy, in Chronic Human Schistosoma Infection.
Marascio N, Loria MT, Pavia G, Peronace C, Adams NJ, Campolo M, Divenuto F, Lamberti AG, Giancotti A, Barreca GS, Mazzitelli M, Trecarichi EM, Torti C, Perandin F, Bisoffi Z, Quirino A, Matera G.
Marascio N, et al. Among authors: perandin f.
Vaccines (Basel). 2023 May 17;11(5):995. doi: 10.3390/vaccines11050995.
Vaccines (Basel). 2023.
PMID: 37243099
Free PMC article.